Document is current
Any future updates will be listed below
-
Authors
Taiber, Shahar https://orcid.org/0000-0002-0787-4216
Cohen, Roie
Yizhar‐Barnea, Ofer https://orcid.org/0000-0002-1953-1982
Sprinzak, David https://orcid.org/0000-0001-6776-6957
Holt, Jeffrey R https://orcid.org/0000-0002-7182-8011
Avraham, Karen B https://orcid.org/0000-0002-4913-251X
-
Funding
Funding for this research was provided by:
National Institute on Deafness and Other Communication Disorders (R01DC011835)
Capita Foundation
H2020 European Research Council (682161)
- License Information
-
More Information
Article History
Received: 8 August 2020
Revised: 10 November 2020
Accepted: 18 November 2020
First Online: 22 December 2020
Conflict of interest
: J.R.H. holds a patent on use of AAV9‐PHP.B for inner ear gene therapy and is an advisor to several biotech companies focused on inner ear therapeutics. The authors declare no other conflict of interests.
